Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day

Journal of Child and Adolescent Psychopharmacology

Volumn 22, Issue 2, 2012, Pages 131-138

  Günther, Thomas ^a   Kahraman Lanzerath, Berrak ^a   Knospe, Eva Lotte ^a   Herpertz Dahlmann, Beate ^b,c   Konrad, Kerstin ^a,c  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c JARA Brain Translational Brain Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; CHILD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; FEMALE; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MALE; MAXIMUM PLASMA CONCENTRATION; MORNING DOSAGE; MOTION ANALYSIS SYSTEM; MOTOR PERFORMANCE; PSYCHOLOGIC TEST; REACTION TIME; RISK REDUCTION; SCHOOL CHILD; SYMPTOM; TASK PERFORMANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CIRCADIAN RHYTHM; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; TIME FACTORS;

EID: 84860001419     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2010.0146     Document Type: Article

References (55)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
2. Baker DB, Taylor CJ, Leyva C: Continuous performance tests: A comparison of modalities. J Clin Psychol 4:548-551, 1995.
3. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E: [Longacting medications for the treatment of hyperkinetic disorders-A systematic review and European treatment guidelines. Part 2: A quantitative evaluation of long-Acting medications]. Z Kinder Jugendpsychiatr Psychother 2:97-106, 2008.
4. Bergfalk H: QbTest User Manual. Gothenburg, Sweden: QbTech AB; 2003.
5. Brocki KC, Tillman CM, Bohlin G: CPT performance, motor activity, and continuous relations to ADHD symptom domains: A developmental study. Eur J Dev Psychol 7:178-197, 2010.
6. Buitelaar J, Medori R: Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: A review of the potential benefits of long-Acting stimulants. Eur J Child Adolesc Psychiatry 4:325-340, 2009.
7. Castellanos FX, Sonuga-Barke EJ, Scheres A, Di Martino A, Hyde C, Walters JR: Varieties of attention-deficit/hyperactivity disorderrelated intra-individual variability. Biol Psychiatry 57:1416-1423, 2005. (Pubitemid 40798563)
8. DeVito EE, Blackwell AD, Clark L, Kent L, Dezsery AM, Turner DC, Aitken MR, Sahakian BJ: Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 1-3:531-539, 2009.
9. Döpfner M, Banaschewski T, Schmidt JK, Uebel H, Schmeck K, Gerber WD, Günter M, Knölker U, Gehrke M, Häßler F, Resch F, Brünger M, Ose C, Fischer R, Poustka F, Rothenberger A, Lehmkuhl G: Langzeitwirksames methylphenidat (medikinet(-Retard) bei kindern mit aufmerksamkeitsdefizit-/hyperaktivitätsstörung-erfolgreiche symptomreduktion und gute verträglichkeit in einer multizentrischen studie. Nervenheilkunde 22:85-92, 2003. (Pubitemid 36401884)
10. Döpfner M, Gerber WD, Banaschewski T, Breuer D, Freisleder FJ, Gerber-von Muller G, Gunter M, Hassler F, Ose C, Rothenberger A, Schmeck K, Sinzig J, Stadler C, Uebel H, Lehmkuhl G: Comparative efficacy of once-A-day extended-release methylphenidate, two-timesdaily immediate-release methylphenidate, and placebo in a laboratory school setting. Eur Child Adolesc Psychiatry 13 Suppl I:93-101, 2004.
11. Döpfner M, Lehmkuhl G: Diagnostik-System für Psychische Störungen im Kindes- und Jugendalter Nach ICD-10/DSM-IV. Göttingen: Hogrefe Testzentrale; 2000.
12. Dougherty DM, Marsh-Richard DM, Hatzis ES, Nouvion SO, Mathias CW: A test of alcohol dose effects on multiple behavioral measures of impulsivity. Drug Alcohol Depend 1-2:111-120, 2008.
13. Egeland J, Johansen SN, Ueland T: Differentiating between ADHD sub-types on CCPT measures of sustained attention and vigilance. Scand J Psychol 4:347-354, 2009.
14. Epstein JN, Conners CK, Hervey AS, Tonev ST, Arnold LE, Abikoff HB, Elliott G, Greenhill LL, Hechtman L, Hoagwood K, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn JH, Pelham WE, Severe JB, Swanson JM, Wells K, Vitiello B, Wigal T: Assessing medication effects in the MTA study using neuropsychological outcomes. J Child Psychol Psychiatry 5:446-456, 2006.
15. Günther T, Herpertz-Dahlmann B, Jolles J, Konrad K: The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder. J Child Adolesc. Psychopharmacol. 6:725-735, 2006. (Pubitemid 46175428)
16. Günther T, Herpertz-Dahlmann B, Konrad K: Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. J Child Adolesc. Psychopharmacol. 3:179-186, 2010.
17. Günther T, Herpertz-Dahlmann B, Konrad K: Reliabilität von Aufmerksamkeits-und verbalen Gedächtnis- Tests bei gesunden Kindern und Jugendlichen-Implikationen für die klinische Praxis. [Reliability of attention and verbal memory tests with normal children and adolescents-clinical implications]. Z Kinder Jugendpsychiatr Psychother 3:169-179, 2005a. (Pubitemid 41103561)
18. Günther T, Holtkamp K, Jolles J, Herpertz-Dahlmann B, Konrad K: The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders. J Child Adolesc. Psychopharmacol. 4:608-618, 2005b. (Pubitemid 41434365)
19. Halperin JM, Matier K, Bedi G, Sharma V, Newcorn JH: Specificity of inattention, impulsivity, and hyperactivity to the diagnosis of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2:190-196, 1992.
20. Hasher L, Lustig C, Zacks R: Inhibitory mechanisms and the control of attention. In: Variation in Working Memory. Edited by A.R.A. Conway, C. Jarrold, M.J. Kane, A. Miyake, J.N. Towse. Oxford: Oxford University Press; 2007: pp. 227-249.
21. Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, Remschmidt H: Objective measurement of hyperactivity, impul-sivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry 2:100-104, 2004. (Pubitemid 38657631)
22. Janvier B, Testu F: Age-related differences in daily attention patterns in preschool, kindergarten, first-grade, and fifth-grade pupils. Chronobiol Int 2:327-343, 2007. (Pubitemid 46643416)
23. Kemner JE, Lage MJ: Effect of methylphenidate formulation on treatment patterns and use of emergency room services. Am J Health Syst Pharm 4:317-322, 2006. (Pubitemid 43244607)
24. Kindlon DJ, Mezzacappa E, Earls F: Psychometric properties of impulsivity measures: Temporal stability, validity and factor structure. J Child Psychol Psychiatry 36:645-661, 1995.
25. King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R: A systematic review and economic model of the effectiveness and costeffectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess 23:iii-iv, xiii-146, 2006.
26. Konrad K, Günther T, Hanisch C, Herpertz-Dahlmann B: Differential effects of methylphenidate on attentional functions in children with attention deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2:191-198, 2004.
27. Konrad K, Günther T, Heinzel-Gutenbrunner M, Herpertz-Dahlmann B: Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial. J Child Adolesc. Psychopharmacol. 2:180-190, 2005.
28. Kraemer S, Danker-Hopfe H, Dorn H, Schmidt A, Ehlert I, Herrmann WM: Time-of-day variations of indicators of attention: Performance, physiologic parameters, and self-Assessment of sleepiness. Biol Psychiatry 11:1069-1080, 2000.
29. Lenne MG, Triggs TJ, Redman JR: Time of day variations in driving performance. Accid Anal Prev 4:431-437, 1997. (Pubitemid 127383872)
30. Matier K, Halperin JM, Sharma V, Newcorn JH, Sathaye N: Methylphenidate response in aggressive and nonaggressive ADHD children: Distinctions on laboratory measures of symptoms. J Am Acad Child Adolesc Psychiatry 2:219-225, 1992.
31. Monk TH, Buysse DJ, Reynolds CFr, Kupfer DJ: Circadian determinants of the postlunch dip in performance. Chronobiol Int 2:123-133, 1996. (Pubitemid 26272993)
32. Nakajima T, Uchiyama M, Enomoto T, Shibui K, Ishibashi K, Kanno O, Okawa M: Human time production under constant routine. Psychiatry Clin Neurosci 2:240-241, 1998. (Pubitemid 28235043)
33. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL, Hechtman L, Hinshaw SP, Hoza B, Kraemer HC, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitello B: Symptom profiles in children with ADHD: Effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry 2:137-146, 2001. (Pubitemid 32111017)
34. Nigg JT: Neuropsychologic theory and findings in attention-deficit/ hyperactivity disorder: The state of the field and salient challenges for the coming decade. Biol Psychiatry 11:1424-1435, 2005. (Pubitemid 40798564)
35. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, Chronis AM, Forehand GL, Nguyen CA, Hoffman MT, Lock TM, Fiebelkorn K, Coles EK, Panahon CJ, Steiner RL, Meichenbaum DL, Onyango AN, Morse GD: Once-Aday Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 6:E105, 2001.
36. Pelz R, Banaschewski T, Becker K: [Methylphenidate of retard forms in children and adolescents with ADHD-An overview]. Klin Pä-diatr 220:93-100, 2008. (Pubitemid 351518688)
37. Porrino LJ, Rapoport JL, Behar D, Ismond DR, Bunney WE: A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 40:681-687, 1983. (Pubitemid 13094937)
38. Reichenbach LC, Halperin JM, Sharma V, Newcorn JH: Children's motor activity: Reliability and relationship to attention and behavior. Dev Neuropsychol 8:87-97, 1992.
39. Rhodes SM, Coghill DR, Matthews K: Acute neuropsychological effects of methylphenidate in stimulant drug-naive boys with ADHD II-broader executive and non-executive domains. J Child Psychol Psychiatry 11:1184-1194, 2006. (Pubitemid 44660621)
40. Rommelse NN, Altink ME, Martin NC, Buschgens CJ, Faraone SV, Buitelaar JK, Sergeant JA, Oosterlaan J: Relationship between endophenotype and phenotype in ADHD. Behav Brain Funct 4:4, 2008.
41. Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE: A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol 1:e50-e62, 2006. (Pubitemid 46165597)
42. Stefanatos GA, Baron IS: Attention-deficit/hyperactvity disorder: A neuropsychological perspective towards DSM-V. Neuropsychol Rev 17:5-38, 2007. (Pubitemid 46355009)
43. Sunohara GA, Malone MA, Rovet J, Humphries T, Roberts W, Taylor MJ: Effect of methylphenidate on attention in children with attention deficit hyperactivity disorder (ADHD): ERP evidence. Neuropsychopharmacology 2:218-228, 1999. (Pubitemid 29304583)
44. Swanson J: Compliance with stimulants for attention-deficit/hyperactivity disorder: Issues and approaches for improvement. CNS Drugs 2:117-131, 2003. (Pubitemid 36194310)
45. Tannock R, Schachar R, Logan GD: Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23:235-266, 1995.
46. Teicher MH: Actigraphy and motion analysis: New tools for psychiatry. Harv Rev Psychiatry 1:18-35, 1995.
47. Teicher MH, Glod CA, Harper D, Magnus E, Brasher C, Wren F, Pahlavan K: Locomotor activity in depressed children and adolescents: I. Circadian dysregulation. J Am Acad Child Adolesc Psychiatry 4:760-769, 1993. (Pubitemid 23187774)
48. Teicher MH, Ito Y, Glod CA, Barber NI: Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 3:334-342, 1996. (Pubitemid 26072291)
49. Teicher MH, Polcari A, Foley M, Valente E, McGreenery CE, Chang WW, McKay G, Midha KK: Methylphenidate blood levels and therapeutic response in children with attention-deficit hyperactivity disorder: I. Effects of different dosing regimens. J Child Adolesc. Psychopharmacol. 4:416-431, 2006. (Pubitemid 44681462)
50. Tewes U, Schallberger U, Rossmann K: Hamburg Wechsler Intelligenztest für Kinder III. [Hamburg Wechsler Intelligence Test for Children III]. Göttingen: Hogrefe; 1999.
51. Unnewehr S, Schneider S, Margraf J: Kinder-DIPS-Diagnostisches Interview bei Psychischen Störungen im Kindes und Jugendalter [Children-DIPS: Diagnostic Interview for Mental Disorders in Childhood and Adolescence]. Heidelberg: Springer; 1995.
52. Van Zomeren AH, Brouwer WJ: Theories and concepts of attention. In: Clinical Neuropsychology of Attention(2). Edited by A.H. Van-Zomeren, W.J. Brouwer. New York, Oxford: Oxford University Press; 1994; pp. 7-38.
53. Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M: ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry 4:424-433, 2003. (Pubitemid 39625077)
54. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Casat C, Denisco MJ, Halstead P, Bloom L, Zimmerman BA, Gu J, Cooper KM, Lynch JM: Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 1:82-90, 2006. (Pubitemid 43042140)
55. Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, Palumbo D, Atkins M, McBurnett K, Bukstein O, August G: Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics 4:883-892, 2001. (Pubitemid 32947657)